Opioid and Other Substance Use Disorders Study Committee Final Report
The Interim Committee on Opiod and other Substance Use Disorders was created pursuant to Section 10-22.3-101.
Second Regular Session | 74th General Assembly
Colorado General AssemblyThe Interim Committee on Opiod and other Substance Use Disorders was created pursuant to Section 10-22.3-101.
This memorandum provides an overview of the 2017 membership of the Opioid and Other Substance Use Disorders Interim Study Committee, the origin and charge of the committee, bill request deadlines and procedures, and information regarding committee staff and the committee website. Information is...
According to the U.S. Census Bureau’s American Community Survey, approximately 10.3 percent of Colorado’s population reported having a disability in 2015. Many of those individuals use a service animal or assistance animal to cope with their disability. This issue brief defines the...
Final Report to the Colorado General Assembly by the Oversight Committee on Mental Illness in the Criminal Justice System.
This issue brief outlines Colorado's efforts to address issues associated with persons with mental illness in the criminal justice system.
Colorado receives annual payments from tobacco manufacturers as part of the Tobacco Master Settlement Agreement. In April 2016, the state received $92.3 million. This memorandum presents the distribution of the 2016 payment and forecasts payments through 2019.
Presented to the Joint Health Committee on January 6, 2017.
Presented to the Joint Health Committee at its meeting on January 6, 2017.
Presented to the Joint Health Committee on January 6, 2017.
Presented to the Joint Health Committee at its January 6, 2017, meeting.
Presented to the Joint Health Committee.
RFP Conduct the 2025 Colorado Property Assessment Study (submit by 3:00 pm, 9/13/2024)